Decompensation of distance exotropia reduces accommodation

Article

Decompensation of distance exotropia reduces accommodation, meaning it must be prevented in near vision.

Decompensation of distance exotropia reduces accommodation, meaning it must be prevented in near vision, reveals a study in the British Journal of Ophthalmology.

The investigation, led by Dr Anna Horwood, School of Psychology & Clinical Language Sciences, University of Reading, Reading, UK, consisted of 19 participants with distance exotropia. Each patient was tested using the PlusoptiXSO4 photo refractor set in a remote haploscopic device.

The refractor recorded simultaneous vergence and accommodation of a range of targets demonstrating the various combinations of blur, disparity and proximal cues. The assessments were made at four fixation distances between 2 m and 33 cm.

The study discovered that manifest exotropia was more common in the more impoverished cue conditions. The mean accommodation increase for the all-cure target was considerably reduced. The mean under-accommodation was 2.33 D at 33 cm. Blur and proximity drove residual responses when the profile of near cues usage changed after decompensation.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.